Sagimet Biosciences Inc (SGMT)
4.09
+0.19
(+4.87%)
USD |
NASDAQ |
May 01, 16:00
4.10
+0.01
(+0.24%)
After-Hours: 20:00
Sagimet Biosciences EPS Diluted (Quarterly): -0.356 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.356 |
| September 30, 2023 | -0.35 |
| June 30, 2023 | -0.306 |
| March 31, 2023 | -0.2971 |
| December 31, 2022 | -0.3245 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.3367 |
| June 30, 2022 | -0.3203 |
| March 31, 2022 | -0.3939 |
| March 31, 2021 | -0.2502 |
| March 31, 2020 | -0.1796 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.3939
Minimum
Mar 2022
-0.1796
Maximum
Mar 2020
-0.3114
Average
-0.3224
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -5.72 |
| 89bio Inc | -0.50 |
| Viking Therapeutics Inc | -0.26 |
| Akero Therapeutics Inc | -1.02 |
| Arrowhead Pharmaceuticals Inc | -1.24 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.151M |
| Total Expenses (Quarterly) | 9.466M |
| Enterprise Value | 35.63M |
| Earnings Yield | -32.01% |